Spark's gene therapy treatment receives 16-0 vote in favor

3:23 PM ET Thu, 12 Oct 2017

CNBC's Meg Tirrell reports that Spark Therapeutics has received a 16-0 vote from an FDA panel in favor of a new genetic treatment to treat a rare, inherited form of blindness